BI-1808 is a human IgG1 monoclonal antibody that targets TNFR2by blocking interaction of TNFR2 with ligand TNF-alpha, confers FcgammaR-dependent depletion of Treg and mediates expansion of intratumoral CD8+ T cells[1].
Molecular Weight:
(144.206 kDa)
Purity:
97.75
Target:
TNF Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
